lymphoma
NeoGenomics, Adaptive Biotech Partner to Offer Combined Blood Cancer Testing
Doctors ordering NeoGenomics Compass test packages will have the option of including Adaptive's Clonoseq minimal residual disease assay.
Roche Gets FDA Clearance for B-Cell Lymphoma Test
The test is designed to differentiate a B-cell malignancy from a normal, reactive response to an infection.
Verismo Therapeutics Receives $4M Investment From Institute for Follicular Lymphoma Innovation
The investment will be used to help increase enrollment of follicular lymphoma patients in an ongoing Phase I study of Verismo's KIR-CAR therapy.
Viracta Therapeutics Closing Pivotal Nana-Val Trial, Exploring Strategic Alternatives
The company said it is having discussions to explore strategic alternatives, such as a merger, licensing agreements, or a sale, with the goal of maximizing value.
Institute for Follicular Lymphoma Innovation Invests $11M in PeproMene Bio's CAR T-Cell Therapy
The firm is developing the BAFF-R-targeted therapy PMB-CT01 for treating B-cell malignancies, including heavily pretreated follicular lymphoma.
Jul 24, 2024